Treatment Group

Variable

0 (n = 532)

1 (n = 522)

2 (n = 524)

3 (n = 561)

P-value

Age

≤ 30

(30,40]

(40,50]

> 50

166 (0.31)

237 (0.45)

102 (0.19)

27 (0.05)

164 (0.31)

233 (0.45)

101 (0.19)

24 (0.05)

164 (0.31)

235 (0.45)

95 (0.18)

30 (0.06)

177 (0.32)

251 (0.45)

111 (0.20)

22 (0.04)

0.984

Weight (kg)

≤ 60

(60,70]

(70,80]

> 80

44 (0.08)

138 (0.26)

177 (0.33)

173 (0.33)

63 (0.12)

126 (0.24)

175 (0.34)

158 (0.30)

58 (0.11)

132 (0.25)

172 (0.33)

162 (0.31)

66 (0.12)

132 (0.24)

192 (0.34)

171 (0.30)

0.749

Hemophilia

No

Yes

490 (0.92)

42 (0.08)

479 (0.92)

43 (0.08)

478 (0.91)

46 (0.09)

512 (0.91)

49 (0.09)

0.946

Homosexual activity

No

Yes

191 (0.36)

341 (0.64)

176 (0.34)

346 (0.66)

176 (0.34)

348 (0.66)

182 (0.32)

379 (0.68)

0.679

Karnofsky score

70

80

90

100

4 (0.01)

17 (0.03)

197 (0.37)

314 (0.59)

0 (0.00)

22 (0.04)

189 (0.36)

311 (0.60)

3 (0.01)

18 (0.03)

180 (0.34)

323 (0.62)

2 (0.00)

23 (0.04)

221 (0.39)

315 (0.56)

0.500

Prior antiretroviral therapy

No

Yes

516 (0.97)

16 (0.03)

513 (0.98)

9 (0.02)

511 (0.98)

13 (0.02)

552 (0.98)

9 (0.02)

0.350

Race

White

Non-white

376 (0.71)

156 (0.29)

384 (0.74)

138 (0.26)

374 (0.71)

150 (0.29)

388 (0.69)

173 (0.31)

0.452

Gender

Female

Male

100 (0.19)

432 (0.81)

88 (0.17)

434 (0.83)

89 (0.17)

435 (0.83)

91 (0.16)

470 (0.84)

0.708

Baseline CD4 count

≤ 15.3

(15.3,18.4]

(18.4,21.6]

> 21.6

75 (0.14)

182 (0.34)

197 (0.37)

78 (0.15)

98 (0.19)

175 (0.34)

171 (0.33)

78 (0.15)

88 (0.17)

175 (0.33)

173 (0.33)

88 (0.17)

86 (0.15)

197 (0.35)

201 (0.36)

77 (0.14)

0.528

Baseline CD8 count

≤ 6.32

(6.32,6.79]

(6.79,7.26]

> 7.26

72 (0.14)

197 (0.37)

190 (0.36)

73 (0.14)

79 (0.15)

173 (0.33)

183 (0.35)

87 (0.17)

69 (0.13)

181 (0.35)

195 (0.37)

79 (0.15)

88 (0.16)

192 (0.34)

203 (0.36)

78 (0.14)

0.813